VIVUS

$1.36
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-8.84%) Today
+$0.02 (+1.49%) As of 4:37 AM EDT after-hours

Why Robinhood?

You can buy or sell VIVUS and other stocks, options, ETFs, and crypto commission-free!

About VVUS

VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Read More Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.

Employees
59
Headquarters
Campbell, California
Founded
1991
Market Cap
15.65M
Price-Earnings Ratio
Dividend Yield
Average Volume
7.28M
High Today
$1.50
Low Today
$1.30
Open Price
$1.40
Volume
2.15M
52 Week High
$4.75
52 Week Low
$0.80

Collections

VVUS News

BenzingaApr 1

Why Vivus Is Trading Lower Today

Vivus (NASDAQ: VVUS) shares were trading lower on Wednesday, after the company priced its 7.22 million share common stock offering at $1.60 per share. Vivus is
327
ReutersApr 1

BRIEF-Vivus Announces $11.55 Mln Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

April 1 (Reuters) - Vivus Inc: * VIVUS ANNOUNCES $11.55 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES * VIVUS INC - ENTERED INTO
83
BenzingaMar 31

Vivus Shares Rally On Accelerated Telemedicine Launch

Shares of biopharma company VIVUS, Inc. (NASDAQ: VVUS) are skyrocketing following an announcement concerning launch plans for telemedicine services. The Campbe
590

VVUS Earnings

-$1.17
-$0.78
-$0.39
$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
per share
Actual
Expected Apr 28, After Hours

People Also Bought

You May Also Like

Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.